Renalytix (RENX) Competitors

Cambridge Cognition (LON:COG) and Renalytix (LON:RENX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation, community ranking and earnings.

Does the MarketBeat Community believe in COG or RENX?

Cambridge Cognition received 82 more outperform votes than Renalytix when rated by MarketBeat users. However, 74.19% of users gave Renalytix an outperform vote while only 44.30% of users gave Cambridge Cognition an outperform vote.

Company	Underperform	Outperform
Cambridge Cognition	Outperform Votes 105 44.30%	Underperform Votes 132 55.70%
Renalytix	Outperform Votes 23 74.19%	Underperform Votes 8 25.81%

Do analysts rate COG or RENX?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cambridge Cognition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Renalytix	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Do insiders and institutionals have more ownership in COG or RENX?

35.2% of Cambridge Cognition shares are held by institutional investors. Comparatively, 28.4% of Renalytix shares are held by institutional investors. 29.9% of Cambridge Cognition shares are held by company insiders. Comparatively, 35.7% of Renalytix shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Which has more risk and volatility, COG or RENX?

Cambridge Cognition has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500. Comparatively, Renalytix has a beta of 2.1, meaning that its stock price is 110% more volatile than the S&P 500.

Does the media favor COG or RENX?

In the previous week, Cambridge Cognition had 3 more articles in the media than Renalytix. MarketBeat recorded 3 mentions for Cambridge Cognition and 0 mentions for Renalytix. Cambridge Cognition's average media sentiment score of 0.28 beat Renalytix's score of 0.00 indicating that Cambridge Cognition is being referred to more favorably in the media.

Company	Overall Sentiment
Cambridge Cognition	Neutral
Renalytix	Neutral

Which has better earnings and valuation, COG or RENX?

Cambridge Cognition has higher revenue and earnings than Renalytix. Cambridge Cognition is trading at a lower price-to-earnings ratio than Renalytix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cambridge Cognition	£13.08M	0.91	-£1.32M	-£0.04	-712.50
Renalytix	£2.29M	5.80	-£33.46M	-£0.24	-33.33

Is COG or RENX more profitable?

Renalytix has a net margin of 0.00% compared to Cambridge Cognition's net margin of -10.07%. Cambridge Cognition's return on equity of -74.36% beat Renalytix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cambridge Cognition	-10.07%	-74.36%	-0.30%
Renalytix	N/A	-1,073.18%	-93.54%

Summary

Cambridge Cognition beats Renalytix on 9 of the 15 factors compared between the two stocks.